1. Portincasa P, Stolk MF, van Erpecum KJ, et al. Cholesterol gallstone formation in man and potential treatments of the
gallbladder motility defect. Scand J Gastroenterol 1995;212:63-78.
2. Kono S, Shinchi K, Todoraki I, et al. Gallstone disease among Japanase men in relation to obesity, glucose intolerance, excersise, alcohol use and smoking. Scand J Gastroenterol 1995;30:372-6.
3. Trotman BW, Soloway RD. Pigment vs cholesterol cholelithiasis: medical and epidemiological aspects. Am J Dig Dis 1978;20:735-40.
4. Redinger RN, Small DM. Bile composition, bile salt metabolism and gallstones. Arch Intern Med 1972;130:618-
30.
5. Calabrese C, Pearlman DM. Gallbladder disease below the age of 21 years. Surgery 1971;70:413-5.
6. Honore LH. Cholesterol cholelithiasis in adolescent females: its connection with obesity, parity and oral contraceptives use- a retrospective study of 31 cases. Arch Surg 1980; 114:
62-4.
7. Van der Linden W, Nakayama F. Gallstone disease in Sweden versus Japan. Clinical and etiologic aspects. Am J
Surg 1973;125:267-72.
8. Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: observations in the Framingham study. J Chr Dis 1966;19:273-92.
9. Bennion LJ, Grundy SM. Effects of obesity and caloric intake on biliary lipid excretion in man and dog. J Clin
Invest 1975;56:996-1011.
10. Gebhard RL, Prigge WF, Ansel HJ, et al. The role of
gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 1996;24:544-8.
11. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man, Part II. N Eng J Med
1978;299:1221-7.
12. Nilson S. Gallbladder disease and sex hormones. A statistical study. Acta Chir Scand 1966;132:275-9.
13. Goodman DB. Cholelithiasis in persons under 25 years old.
JAMA 1976;236:1731-2.
14. Thistle JL, Eckhart KL, Nensel RE, et al. Prevalence of gallbladder disease among Chippewa Indians. Mayo Clin
Proc 1971;46:603-8.
15. Braverman DZ, Johnson ML, Kern F. Effects of pregnancy and contraceptive steroids on gallbladder function. N Eng J
Med 1980;302:362-4.
16. Stolley PD, Tonascia JA, Tockman MS, et al. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol
1975;102:197-208.
17. Howat JMT, Jones CB, Schofield PF. Gallstones and oral contraceptives. J Int Med Res 1975;31:59-62
18. Royal College of General Practitioners' oral contraceptive study. Oral contraceptives and gallbladder disease. Lancet
1982;2:957-9.
19. Boston Collaborative Drug Surveillance Program: Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to post-menopausal estrogen therapy. N Engl J Med 1974;290:15.
20. Sampliner RE, Bennett PH, Comess LJ, et al. Gallbladder disease in Pima Indians: demonstration of high prevalence and early onset by cholecystography. N Engl J Med
1970,283:1358-64.
21. Miettinen M, Turpeinen O, Karvonen VJ, et al. Prevalence of cholelithiasis in men and women ingesting a serum-cholesterol-lowering diet. Ann Clin Res 1976;8:111-6.
22. Nagase M, Tanimura H, Setoyama M, Hikasa Y. Present features of gallstones in Japan: a collective review of 2,144
cases. Am J Surg 1978;135:788-90.
23. Bouchier IAD. Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver Gut
1969;10:705-9.
24. Chapman BA, Wilson IR, Frampton CM, et al. Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci
1996;41:2222-8.
25. Hahm JS, Park JY, Park KG, et al. Gallbladder motility in
diabetes mellitus using real time ultrasonography. Am J Gastroenterol 1996;91:2391-4.
Thank you for copying data from http://www.arastirmax.com